scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0960-894X(99)00235-8 |
P698 | PubMed publication ID | 10386942 |
P2093 | author name string | C Mao | |
T K Venkatachalam | |||
F M Uckun | |||
E A Sudbeck | |||
P2860 | cites work | High resolution structures of HIV-1 RT from four RT-inhibitor complexes | Q27729427 |
The structure of HIV-1 reverse transcriptase complexed with 9-chloro-TIBO: lessons for inhibitor design | Q27732214 | ||
The PETT series, a new class of potent nonnucleoside inhibitors of human immunodeficiency virus type 1 reverse transcriptase | Q28367759 | ||
Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase | Q28369309 | ||
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor | Q29547710 | ||
The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure | Q34326042 | ||
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance | Q40394618 | ||
Synthesis and anti-HIV activities of urea-PETT analogs belonging to a new class of potent non-nucleoside HIV-1 reverse transcriptase inhibitors | Q40984542 | ||
Dihydro(alkylthio)(naphthylmethyl)oxopyrimidines: novel non-nucleoside reverse transcriptase inhibitors of the S-DABO series | Q41110624 | ||
Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs | Q41260272 | ||
Synthesis and anti-HIV-1 activity of thio analogues of dihydroalkoxybenzyloxopyrimidines. | Q41309346 | ||
Structure-based design of N-[2-(1-piperidinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea and N-[2-(1-piperazinylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea as potent non-nucleoside inhibitors of HIV-1 reverse transcriptase | Q42537167 | ||
5-Alkyl-2-[(methylthiomethyl)thio]-6-(benzyl)-pyrimidin-4-(1H)-ones as potent non-nucleoside reverse transcriptase inhibitors of S-DABO series | Q42537190 | ||
Inhibition of human immunodeficiency virus type 1 wild-type and mutant reverse transcriptases by the phenyl ethyl thiazolyl thiourea derivatives trovirdine and MSC-127. | Q42555835 | ||
LUDI: rule-based automatic design of new substituents for enzyme inhibitor leads | Q44114180 | ||
Scintillation proximity assay | Q59062768 | ||
Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reserve transcriptase | Q77634517 | ||
P433 | issue | 11 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1593-8 | |
P577 | publication date | 1999-06-07 | |
P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
P1476 | title | Rational design of N-[2-(2,5-dimethoxyphenylethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-236) as a potent non-nucleoside inhibitor of drug-resistant human immunodeficiency virus | |
P478 | volume | 9 |
Q37980177 | A novel vaginal microbicide containing the rationally designed anti-HIV compound HI-443 (N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea]). |
Q32068291 | Anti-HIV activity of aromatic and heterocyclic thiazolyl thiourea compounds |
Q37091525 | C-2-aryl O-substituted HI-236 derivatives as non-nucleoside HIV-1 reverse-transcriptase inhibitors |
Q43789990 | C-H activation with elemental sulfur: synthesis of cyclic thioureas from formaldehyde aminals and S8. |
Q48123897 | Evaluation of the pharmacokinetic features and tissue distribution of the potent nonnucleoside inhibitor of HIV-1 reverse transcriptase, N-[2-(2-fluorophenethyl)]-N'-[2-(5-bromopyridyl)]-thiourea (HI-240) with an analytical HPLC method |
Q44301664 | Inhibition of mast cell leukotriene release by thiourea derivatives |
Q28378241 | N'-[2-(2-thiophene)ethyl]-N'-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1 |
Q28373540 | N-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea and N'-[2-(1-cyclohexenyl)ethyl]-N'-[2-(5-chloropyridyl)]-thiourea as potent inhibitors of multidrug-resistant human immunodeficiency virus-1 |
Q43503283 | N-[2-(4-methylphenyl)ethyl]-N'-[2-(5-bromopyridyl)]-thiourea as a potent inhibitor of NNRTI-resistant and multidrug-resistant human immunodeficiency virus type 1. |
Q34944447 | New anti-HIV agents and targets |
Q56786460 | New developments in anti-HIV chemotherapy |
Q34248509 | New developments in anti-HIV chemotherapy. |
Q34481618 | Non-nucleoside reverse transcriptase inhibitors: perspectives on novel therapeutic compounds and strategies for the treatment of HIV infection |
Q33966254 | Novel compounds in preclinical/early clinical development for the treatment of HIV infections |
Q36632128 | Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase |
Q27621483 | Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses |
Q43516121 | Piperidinylethyl, phenoxyethyl and fluoroethyl bromopyridyl thiourea compounds with potent anti-HIV activity |
Q44327069 | Potent dual anti-HIV and spermicidal activities of novel oxovanadium(V) complexes with thiourea non-nucleoside inhibitors of HIV-1 reverse transcriptase |
Q43842299 | Stereochemistry as a major determinant of the anti-HIV activity of chiral naphthyl thiourea compounds |
Q43507367 | Stereochemistry of halopyridyl and thiazolyl thiourea compounds is a major determinant of their potency as nonnucleoside inhibitors of HIV-1 reverse transcriptase |
Q34047516 | Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase |
Q44340757 | Substituted heterocyclic thiourea compounds as a new class of anti-allergic agents inhibiting IgE/Fc epsilon RI receptor mediated mast cell leukotriene release |
Q42715656 | Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents. |
Q34242282 | [d4U]-spacer-[HI-236] double-drug inhibitors of HIV-1 reverse-transcriptase. |
Search more.